| 產(chǎn)品名稱 |
38.1 |
| 商品貨號 |
B163720 |
| Organism |
Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type |
hybridoma: B lymphocyte |
| Product Format |
frozen |
| Morphology |
lymphoblast |
| Culture Properties |
suspension |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications |
The antibody reacts with the Tp19-29 antigen associated with human T cells (CD3). |
| Derivation |
Spleen cells were fused with NSI/1 myeloma cells. |
| Genes Expressed |
immunoglobulin; monoclonal antibody; against human CD3 |
| Cellular Products |
immunoglobulin; monoclonal antibody; against human CD3 |
| Comments |
Animals were immunized with human peripheral blood T lymphocytes. Spleen cells were fused with NSI/1 myeloma cells. The antibody reacts with the Tp19-29 antigen associated with human T cells (CD3). The antibody moderately inhibits alloreactive cytotoxic T lymphocyte activity and is weakly mitogenic for peripheral blood lymphocytes. |
| Complete Growth Medium |
The base medium for this cell line is ATCC Hybri-Care Medium, Catalog No. 46-X. Hybri-Care Medium is supplied as a powder and should be reconstituted in 1 L cell culture grade water. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10% 1.5 g/L sodium bicarbonate for use with 5% CO2 in air atmosphere.
|
| Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 1 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 5 X 10 exp5 cells/ml. |
| Isotype |
IgM |
| Name of Depositor |
PJ Martin |
| Deposited As |
mouse (B cell); mouse (myeloma) |
| References |
. Leucocyte typing: human leucocyte differentiation antig ens detected by monoclonal antibodies. New York: Springer-Verlag; 1984.
|
